Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

Equity Capital Markets

<ul>
<li>Bluemtec is getting ready to complete its IPO in KOSDAQ in the next several weeks. Bluemtec operates the number one pharmaceutical e-commerce platform in Korea. </li>
<li>The company is offering 1.4 million shares in this IPO. The IPO price range is from 15,000 won to 19,000 won.</li>
<li>The company sales and gross profit growth increased impressively in the past several years. The company's sales increased at a CAGR of 60.5% from 2020 to 2022.</li>
</ul>


Bluemtec is getting ready to complete its IPO in KOSDAQ in the next several weeks. Bluemtec operates the number one pharmaceutical e-commerce platform in Korea. 
The company is offering 1.4 million shares in this IPO. The IPO price range is from 15,000 won to 19,000 won.
The company sales and gross profit growth increased impressively in the past several years. The company's sales increased at a CAGR of 60.5% from 2020 to 2022.


Bluemtec

Bluemtec IPO Preview